Bovine immature oocytes acquire developmental competence during meiotic arrest in vitro.
To test the hypothesis that oocytes require time to acquire developmental competence during meiotic arrest, we investigated the effects of butyrolactone I (BL I), a potent and specific inhibitor of cyclin-dependent kinase, on the developmental competence of bovine oocytes after in vitro fertilization (IVF) following release from meiotic arrest. In the present study, 4 culture conditions were used: addition of BSA or fetal bovine serum (FBS) under 2 oxygen tensions (5% vs. 20%) during meiotic arrest with 100-microM BL I. The developmental competence to the blastocyst stage was higher (P < 0.01) in oocytes that were arrested in FBS-supplemented medium under 5% O2 (37%) than in oocytes that were arrested under other conditions (5%-24%) or that matured directly following follicle aspiration (23%). The time course of nuclear maturation of BL I-treated oocytes was also examined. The results demonstrated that oocytes treated with BL I start germinal vesicle (GV) breakdown and reach the metaphase II stage 5.5-6.0 h earlier than nonarrested oocytes. The developmental rates to the blastocyst stage of BL I-treated oocytes matured for 15.5 and 21 h were higher (P < 0.05) than those of nontreated oocytes matured for 21 and 26.5 h, respectively. These results demonstrate that bovine immature oocytes, which were arrested at the GV stage with BL I in FBS-supplemented medium under low oxygen tension, acquire higher developmental competence during meiotic arrest.
Hashimoto
Shu
S
Embryo Transplantation Laboratory, Snow Brand Milk Products Co. Ltd., 119 Uenae, Tomakomai, Hokkaido 059-1365, Japan.
Minami
Naojiro
N
Takakura
Ryo
R
Imai
Hiroshi
H
D015107:4-Butyrolactone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D001755:Blastocyst / Q000502:physiology; D002417:Cattle / Q000502:physiology*; D002467:Cell Nucleus / Q000502:physiology; D002478:Cells, Cultured; D003470:Culture Media; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary; D005312:Fetal Blood; D007700:Kinetics; D008540:Meiosis / Q000187:drug effects; D009865:Oocytes / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D010100:Oxygen / Q000008:administration & dosage; D012710:Serum Albumin, Bovine; D020858:Tissue and Organ Harvesting
D003470:Culture Media; D012710:Serum Albumin, Bovine; C082868:butyrolactone I; D015107:4-Butyrolactone; D010100:Oxygen